Federated Hermes
HRMY icon

Federated Hermes’s Harmony Biosciences HRMY Stock Holding History

Federated Hermes’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.5M Buy
288,257
+9,127
+3% +$288K 0.02% 680
2026
Q1 		$7.82M Buy
279,130
+15,287
+6% +$501K 0.01% 706
2025
Q4 		$9.87M Sell
263,843
-34,393
-12% -$1.13M 0.02% 617
2025
Q3 		$8.22M Buy
298,236
+4,394
+1% +$151K 0.01% 610
2025
Q2 		$9.29M Sell
293,842
-146,042
-33% -$4.7M 0.02% 588
2025
Q1 		$14.6M Sell
439,884
-52,919
-11% -$1.9M 0.03% 471
2024
Q4 		$17M Sell
492,803
-49,276
-9% -$1.69M 0.04% 444
2024
Q3 		$21.7M Buy
542,079
+16,555
+3% +$581K 0.05% 405
2024
Q2 		$15.9M Sell
525,524
-17
-0% -$511 0.04% 447
2024
Q1 		$17.6M Buy
525,541
+204
+0% +$6.55K 0.04% 441
2023
Q4 		$17M Buy
525,337
+501,809
+2,133% +$14M 0.04% 426
2023
Q3 		$771K Buy
23,528
+355
+2% +$12.3K ﹤0.01% 1208
2023
Q2 		$815K Sell
23,173
-15,363
-40% -$530K ﹤0.01% 1204
2023
Q1 		$1.26M Buy
38,536
+9,013
+31% +$410K ﹤0.01% 1097
2022
Q4 		$1.63M Buy
29,523
+2,242
+8% +$123K ﹤0.01% 978
2022
Q3 		$1.21M Sell
27,281
-12,120
-31% -$591K ﹤0.01% 1061
2022
Q2 		$1.92M Buy
39,401
+11,146
+39% +$502K 0.01% 941
2022
Q1 		$1.38M Buy
+28,255
New +$1.15M ﹤0.01% 1137

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Federated Hermes's HRMY Position: Q2 2026 in Review

Federated Hermes increased its Harmony Biosciences (HRMY) stake by 3.3% in Q2 2026, buying an estimated $288K and bringing the position to 288,257 shares worth $10.5M. The position accounts for 0.02% of the portfolio, ranked #680.

Federated Hermes first reported a position in HRMY in Q1 2022 and has held it in 18 quarters since. The position peaked at $21.7M in Q3 2024. 328 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Federated Hermes held 288,257 shares of Harmony Biosciences worth $10.5M as of Q2 2026.
  • Federated Hermes bought 9,127 Harmony Biosciences shares in Q2 2026, an estimated $288K.
  • Harmony Biosciences made up 0.02% of Federated Hermes's portfolio in Q2 2026, its #680 holding.
  • Federated Hermes first reported a position in Harmony Biosciences in Q1 2022 and has held it in 18 quarters since.
  • Federated Hermes's Harmony Biosciences position peaked at $21.7M in Q3 2024.
  • 328 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.